NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









xCures

xCures

Private
Oakland, CaliforniaHealthcare & Life Scienceshttps://xcures.com/

Last Round

Series B

Jun 24, 2026

Est. Valuation

$127M

Total Funding Raised

$61.09M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

xCures is a healthcare technology company that operates an AI-assisted platform to aggregate, normalize, and structure fragmented medical records into a searchable database for clinical insights.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Healthcare Analytics, Biotechnology, Data Integration

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

real-world evidenceRWEreal-world dataclinical trial matchingRWDclinical data aggregationclinical trial softwareoncology researchEHR integrationclinical data platformpatient access serviceshealth data interoperabilityTEFCAclinical trial recruitmenthealthcare SaaSdata normalization

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

xCures Comps

Public and private peers based on sector, stage, and business model.

xCures comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

xCures Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJun 24, 2026
Series AJun 23, 2021
Convertible DebtAug 19, 2020

Key People

Founding team and executive leadership

Mika Newton

Chief Executive Officer

Executive Team

Glenn Kramer

Chief Technology Officer

Executive Team

xCures Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 24, 2026

    $46M round led by Innovius Capital.

  • Apr 20, 2026

    Commercial team is scaling from 2 to over 10 representatives.

xCures Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

xCures Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about xCures's valuation, stock price, and market status.

Firmographic Details

HeadquartersOakland, California
Employee Range62
Year Founded2018
Last FundingJun 24, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.